Agency deficiencies
Severity: majorRespond to agency requests within the prescribed timeline.
Issued April 17, 2024
Issued
April 17, 2024
Application
NDA 505b1 • 218762
Review center
CDER
Stage
Final Decision
Letter type
Complete Response Letter
This section serves as an attestation for an electronic record, confirming it was signed electronically and providing details of the electronic signature, including the date, time, and a reference ID.
No specific deficiencies could be extracted from the provided truncated letter.
Respond to agency requests within the prescribed timeline.
No specific themes could be extracted from the provided truncated letter.
Regulatory change impact: Pending sponsor mitigation plan
Approval likelihood after response: 25%
Document viewer
Read the FDA letter and send context to the co-pilot at any time.